Securities Code: 002118
Securities Abbreviation: *ST Zixin
Announcement Number: 2023-082
Jilin Zixin Pharmaceutical Co., Ltd. announces the tenth risk warning regarding the potential termination of its stock listing due to the stock price being below par value. The company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- According to Article 9.2.1 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," as of June 14, 2023, the company's stock closing price was 0.39 CNY/share, and the stock price has been below 1 CNY for nineteen consecutive trading days. Even if the stock price hits the daily limit up on the next trading day, it will still trigger the delisting criteria due to the stock price being below 1 CNY for twenty consecutive trading days. If this delisting criterion is triggered, the Shenzhen Stock Exchange will make a decision to terminate the listing of the company's stock within the prescribed period, and the stock will not enter the delisting adjustment period.
- According to Article 9.2.3 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," the company must disclose a risk warning announcement regarding the potential termination of its stock listing due to the stock price being below par value. This announcement will be disclosed daily until the relevant situation is resolved or until the Shenzhen Stock Exchange makes a decision to terminate the listing of the company's stock. Investors are advised to invest rationally and pay attention to risks.